Lipoabdominoplasty in Obese Patients: Is It Safe? Has Good Results?

Fibrin Sealant and Lipoabdominoplasty in Obese Grade 1 and 2 Patients

BACKGROUND Ever since lipoabdominoplasty was first developed to achieve better aesthetic outcomes and less morbidity, the rate of seroma formation, especially in obese patients, has disturbed plastic surgeons. The aim of this study was to evaluate the effect of fibrin sealant in the prevention of seroma formation after lipoabdominoplasty in obese patients. METHODS Sixty patients with a body m...

Classification for indications of lipoabdominoplasty and its variations.

BACKGROUND Lipoabdominoplasty, the combination of lipoplasty with classical abdominoplasty, presents new opportunities for the treatment of abdominal lipodystrophy. OBJECTIVE The author analyzed 211 patients who underwent lipoabdominoplasty from 2000 to 2004. METHODS After the preoperative physical examination, the patients were classified into 9 different groups according to the indication...

Lipoabdominoplasty: A versatile and safe technique for abdominal contouring

Commentary on: Lipoabdominoplasty Without Drains or Progressive Tension Sutures: An Analysis of 100 Consecutive Patients.

BACKGROUND Subcutaneous surgical drains are commonly used in abdominoplasties to prevent seromas but are not tolerated well by patients and add additional discomfort after the procedure. The lipoabdominoplasty modification may create a more favorable surgical field to reduce the need for surgical drains without increasing seroma formation. OBJECTIVES The goal of this review was to determine i...

Effects of metformin on weight loss and metabolic control in obese patients with schizophrenia and schizoaffective disorder: a randomized, double-blind, controlled clinical trial

Abstract Objective: The effect of metformin on weight changes and some metabolic parameters in patients with schizophrenia and schizoaffective disorder was investigated in this study. Methods:  This study, performed during 2018-2019, was a randomized, double-blind, controlled clinical trial. A total of 66 obese patients (BMI≥27) with schizophrenia and schizoaffective disorder, hospitalized in...